Treatment News : New HIV Diagnoses Spike Alarmingly Among London Gays

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » August 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


August 1, 2013

New HIV Diagnoses Spike Alarmingly Among London Gays

The number of new HIV diagnoses among gay men in London is rising rapidly—a shift possibly due in part to expanded testing but also likely influenced by a heavy drug culture’s contribution to high-risk sex, The Lancet reports. New data released by Public Health England reports that 1,420 gay men in London were diagnosed with HIV in 2011, compared with 1,720 new diagnoses in 2012, representing a 21 percent spike. A revised figure for 2012 could eventually put the number of new infections at 1,900 in 2012, which would translate to a 33 percent one-year increase.

Across the United Kingdom, 3,240 men who have sex with men (MSM) were diagnosed with HIV in 2012, up 8 percent from 3,010 diagnoses in 2011.  

The increase in HIV diagnoses among London gay men may be partly the result of a 17 percent uptick in HIV tests, over 43,000 of which were conducted among the population in 2012, compared with 37,000 the year before. Anecdotal evidence suggests, however, that recreational or club drug use among gay men in London is an increasing problem and may contribute to the spread of HIV. This includes smoking, injecting or snorting drugs such as crystal meth and mephedrone, which often takes place in connection with sex parties.

To read the Lancet paper, click here.

To read the Public Health England report, click here.

Search: London, HIV, gay men, drug, high-risk sex, The Lancet, new diagnoses, mephedrone, crystal meth.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.